Cooper Net Acquisitions/Divestitures 2012-2026 | COO
Cooper annual/quarterly net acquisitions/divestitures history and growth rate from 2012 to 2026. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
- Cooper net acquisitions/divestitures for the quarter ending April 30, 2026 were $-0.011B, a 96.94% decline year-over-year.
- Cooper net acquisitions/divestitures for the twelve months ending April 30, 2026 were $-0.036B, a 96.38% decline year-over-year.
- Cooper annual net acquisitions/divestitures for 2025 were $-0.011B, a 96.94% decline from 2024.
- Cooper annual net acquisitions/divestitures for 2024 were $-0.343B, a 507.79% increase from 2023.
- Cooper annual net acquisitions/divestitures for 2023 were $-0.057B, a 96.44% decline from 2022.
|
Cooper Annual Net Acquisitions/Divestitures (Millions of US $) |
|
|---|---|
| 2025 | $-11 |
| 2024 | $-343 |
| 2023 | $-57 |
| 2022 | $-1,589 |
| 2021 | $-236 |
| 2020 | $-54 |
| 2019 | $-59 |
| 2018 | $-1,324 |
| 2017 | $-254 |
| 2016 | $-266 |
| 2015 | $-45 |
| 2014 | $-1,110 |
| 2013 | $-13 |
| 2012 | $-145 |
| 2011 | $-58 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.894B | $4.092B |
| The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |